BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18066112)

  • 1. In vitro activity of uva-ursi against cytochrome P450 isoenzymes and P-glycoprotein.
    Chauhan B; Yu C; Krantis A; Scott I; Arnason JT; Marles RJ; Foster BC
    Can J Physiol Pharmacol; 2007 Nov; 85(11):1099-107. PubMed ID: 18066112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic.
    Foster BC; Foster MS; Vandenhoek S; Krantis A; Budzinski JW; Arnason JT; Gallicano KD; Choudri S
    J Pharm Pharm Sci; 2001; 4(2):176-84. PubMed ID: 11466175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato.
    Nair VD; Foster BC; Thor Arnason J; Mills EJ; Kanfer I
    Phytomedicine; 2007 Aug; 14(7-8):498-507. PubMed ID: 17336049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of in vitro inhibitors against UDP-glucuronosyltransferase 1A1 in uva-ursi extracts and evaluation of in vivo uva-ursi-drug interactions.
    Park JB; Kim D; Min JS; Jeong S; Cho DY; Zheng YF; Yoon KD; Bae SK
    Food Chem Toxicol; 2018 Oct; 120():651-661. PubMed ID: 30075316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of zolpidem on human cytochrome P450 activity, and on transport mediated by P-glycoprotein.
    von Moltke LL; Weemhoff JL; Perloff MD; Hesse LM; Harmatz JS; Roth-Schechter BF; Greenblatt DJ
    Biopharm Drug Dispos; 2002 Dec; 23(9):361-7. PubMed ID: 12469329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPTLC densitometric analysis of arbutin in bulk drug and methanolic extracts of Arctostaphylos uva-ursi.
    Alam P; Alqasoumi SI; Shakeel F; Abdel-Kader MS
    Nat Prod Res; 2011 Oct; 25(17):1671-5. PubMed ID: 21331974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products.
    Foster BC; Vandenhoek S; Hana J; Krantis A; Akhtar MH; Bryan M; Budzinski JW; Ramputh A; Arnason JT
    Phytomedicine; 2003 May; 10(4):334-42. PubMed ID: 12809364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.
    Wang Y; Jiang YM; Wang YT; Kang JW; Yu T; Zhao HY; Bian BL; Huang M; Bi HC
    J Ethnopharmacol; 2014 Oct; 156():175-81. PubMed ID: 25219605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UHPLC-PDA-ESI-TOF/MS metabolic profiling of Arctostaphylos pungens and Arctostaphylos uva-ursi. A comparative study of phenolic compounds from leaf methanolic extracts.
    Panusa A; Petrucci R; Marrosu G; Multari G; Gallo FR
    Phytochemistry; 2015 Jul; 115():79-88. PubMed ID: 25702282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in Population and Solvents as Factors Determining the Chemical Composition and Antioxidant Potential of
    Sugier P; Sęczyk Ł; Sugier D
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteome changes in human bladder T24 cells induced by hydroquinone derived from Arctostaphylos uva-ursi herbal preparation.
    Huđek Turković A; Gunjača M; Marjanović M; Lovrić M; Butorac A; Rašić D; Peraica M; Vujčić Bok V; Šola I; Rusak G; Durgo K
    J Ethnopharmacol; 2022 May; 289():115092. PubMed ID: 35143933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of obesity on the cytochrome P450 enzyme system.
    Kotlyar M; Carson SW
    Int J Clin Pharmacol Ther; 1999 Jan; 37(1):8-19. PubMed ID: 10027478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological studies on leaf of Arctostaphylos uva-ursi (L.) Spreng. IV. Effect of 50% methanolic extract from Arctostaphylos uva-ursi (L.) Spreng. (bearberry leaf) on melanin synthesis].
    Matsuda H; Nakamura S; Shiomoto H; Tanaka T; Kubo M
    Yakugaku Zasshi; 1992 Apr; 112(4):276-82. PubMed ID: 1403661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
    Etheridge AS; Black SR; Patel PR; So J; Mathews JM
    Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Antibacterial and Anti-Inflammatory Activity of
    Dell'Annunziata F; Cometa S; Della Marca R; Busto F; Folliero V; Franci G; Galdiero M; De Giglio E; De Filippis A
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145700
    [No Abstract]   [Full Text] [Related]  

  • 16. Actions of ethnobotanically selected Cree anti-diabetic plants on human cytochrome P450 isoforms and flavin-containing monooxygenase 3.
    Tam TW; Liu R; Arnason JT; Krantis A; Staines WA; Haddad PS; Foster BC
    J Ethnopharmacol; 2009 Oct; 126(1):119-26. PubMed ID: 19665535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a quantitative assay of arbutin using gas chromatography in Origanum majorana and Arctostaphylos uva-ursi extracts.
    Lamien-Meda A; Lukas B; Schmiderer C; Franz C; Novak J
    Phytochem Anal; 2009; 20(5):416-20. PubMed ID: 19609883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an on-line high performance liquid chromatography detection system for human cytochrome P450 1A2 inhibitors in extracts of natural products.
    Jeurissen SM; Claassen FW; Havlik J; Bouwmans EE; Cnubben NH; Sudhölter EJ; Rietjens IM; van Beek TA
    J Chromatogr A; 2007 Feb; 1141(1):81-9. PubMed ID: 17184784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
    Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.
    Wandel C; Kim RB; Guengerich FP; Wood AJ
    Drug Metab Dispos; 2000 Aug; 28(8):895-8. PubMed ID: 10901697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.